Biggest changeRevenues and the components of EBITDA for the periods presented are reflected in the tables below for our reportable segments: Year Ended December 31, Millions of dollars 2023 2022 Sales and other operating revenues: O&P-Americas $ 11,280 $ 14,480 O&P-EAI 10,479 13,455 I&D 11,086 12,950 APS 3,698 4,202 Refining 9,714 11,893 Technology 663 693 Other, including segment eliminations (5,813) (7,222) Total $ 41,107 $ 50,451 Operating income (loss): O&P-Americas $ 1,665 $ 2,206 O&P-EAI (160) 75 I&D 1,262 1,604 APS (261) 16 Refining 221 889 Technology 334 331 Other, including segment eliminations (8) (20) Total $ 3,053 $ 5,101 Depreciation and amortization: O&P-Americas $ 587 $ 591 O&P-EAI 207 171 I&D 443 332 APS 98 95 Refining 158 39 Technology 41 39 Total $ 1,534 $ 1,267 Income (loss) from equity investments: O&P-Americas $ 49 $ 98 O&P-EAI (55) (68) I&D (13) (25) APS (1) — Total $ (20) $ 5 43 Table of Conte nts Year Ended December 31, Millions of dollars 2023 2022 Other (expense) income, net: O&P-Americas $ 2 $ (30) O&P-EAI (1) — I&D (13) (39) APS 2 4 Refining — (7) Technology — (4) Other, including intersegment eliminations (48) 4 Total $ (58) $ (72) EBITDA: O&P-Americas $ 2,303 $ 2,865 O&P-EAI (9) 178 I&D 1,679 1,872 APS (162) 115 Refining 379 921 Technology 375 366 Other, including intersegment eliminations (56) (16) Total $ 4,509 $ 6,301 Olefins and Polyolefins-Americas Segment Overview —EBITDA decreased in 2023 relative to 2022 primarily driven by lower polyolefin margins.
Biggest changeRevenues and other information for the periods presented are reflected in the tables below for our reportable segments: Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues: O&P-Americas segment $ 11,533 $ 11,280 O&P-EAI segment 10,867 10,479 I&D segment 10,424 11,086 APS segment 3,634 3,698 Refining segment 8,559 9,714 Technology segment 671 663 Other, including intersegment eliminations (5,386) (5,813) Total $ 40,302 $ 41,107 Operating income (loss): O&P-Americas segment $ 1,805 $ 1,665 O&P-EAI segment (1,008) (160) I&D segment 951 1,262 APS segment (48) (261) Refining segment (213) 221 Technology segment 338 334 Other, including intersegment eliminations (8) (8) Total $ 1,817 $ 3,053 38 Table of Conten ts Year Ended December 31, Millions of dollars 2024 2023 Depreciation and amortization: O&P-Americas segment $ 619 $ 587 O&P-EAI segment 220 207 I&D segment 401 443 APS segment 90 98 Refining segment 150 158 Technology segment 42 41 Total $ 1,522 $ 1,534 Income (loss) from equity investments: O&P-Americas segment $ 13 $ 49 O&P-EAI segment (217) (55) I&D segment (13) (13) APS segment — (1) Total $ (217) $ (20) Impairments: O&P-Americas segment $ — $ 25 O&P-EAI segment 892 38 I&D segment 2 192 APS segment 55 252 Refining segment — 11 Total $ 949 $ 518 Gain on sale of business: I&D segment $ 284 $ — Total $ 284 $ — Other income (expense), net: O&P-Americas segment $ 8 $ 2 O&P-EAI segment 14 (1) I&D segment 41 (13) APS segment 12 2 Refining segment 3 — Technology segment (1) — Other, including intersegment eliminations (27) (48) Total $ 50 $ (58) EBITDA: O&P-Americas segment $ 2,445 $ 2,303 O&P-EAI segment (991) (9) I&D segment 1,664 1,679 APS segment 54 (162) Refining segment (60) 379 Technology segment 379 375 Other, including intersegment eliminations (35) (56) Total $ 3,456 $ 4,509 39 Table of Conten ts Olefins and Polyolefins-Americas Segment Overview —EBITDA increased in 2024 relative to 2023 primarily due to improved olefins margins, partially offset by lower polymer margins.
In calculating the impact of margin and volume on EBITDA, consistent with industry practice, management offsets revenues and volumes related to ethylene co-products against the cost to produce ethylene. Volume and price impacts of ethylene co-products are reported in margin.
In calculating the impact of margin and volume on EBITDA, consistent with industry practice, management offsets revenues and volumes related to ethylene co-products against the cost to produce ethylene. Volume and price impacts of ethylene co-products are reported in margin.
Accordingly, our cost of sales and results of operations may be affected by such fluctuations. We do not believe any of our inventory is at risk for impairment at this time, however as prices for our products and raw materials are inherently volatile and therefore no prediction can be given with certainty.
Accordingly, our cost of sales and results of operations may be affected by such fluctuations. We do not believe any of our inventory is at risk for impairment at this time, however as prices for our products and raw materials are inherently volatile, no prediction can be given with certainty.
Ethylene Raw Materials —Ethylene and its co-products are produced from two major raw material groups: • NGLs, principally ethane and propane, the prices of which are generally affected by natural gas prices; and • crude oil-based liquids (“liquids” or “heavy liquids”), including naphtha, condensates and gas oils, the prices of which are generally related to crude oil prices.
Ethylene Raw Materials —Ethylene and its co-products are produced from two major raw material groups: • natural gas liquids (“NGLs”), principally ethane and propane, the prices of which are generally affected by natural gas prices; and • crude oil-based liquids (“liquids” or “heavy liquids”), including naphtha, condensates and gas oils, the prices of which are generally related to crude oil prices.
On an annual basis, feedstock and energy related costs generally represent approximately 70% to 80% of cost of sales. Other variable costs account for approximately 10% of cost of sales and fixed operating costs, consisting primarily of expenses associated with employee compensation, depreciation and amortization, and maintenance, account for the remainder.
On an annual basis, feedstock and energy related costs generally represent approximately 75% to 80% of cost of sales. Other variable costs account for approximately 10% of cost of sales and fixed operating costs, consisting primarily of expenses associated with employee compensation, depreciation and amortization, and maintenance, account for the remainder.
Availability under this facility is net of outstanding borrowings, outstanding letters of credit provided under the facility and notes issued under our commercial paper program. At December 31, 2023, we had no outstanding borrowings of commercial paper, and no borrowings or letters of credit outstanding under this facility; and • $900 million under our $900 million U.S. Receivables Facility.
Availability under this facility is net of outstanding borrowings, outstanding letters of credit provided under the facility and notes issued under our commercial paper program. At December 31, 2024, we had no outstanding commercial paper and no borrowings or letters of credit outstanding under this facility; and • $900 million under our $900 million U.S. Receivables Facility.
The following table reflects the sensitivity of the benefit obligations and the net periodic benefit costs of our pension plans to changes in the actuarial assumptions: Effects on Benefit Obligations in 2023 Effects on Net Periodic Pension Costs in 2024 Millions of dollars U.S. Non-U.S. U.S. Non-U.S.
The following table reflects the sensitivity of the benefit obligations and the net periodic benefit costs of our pension plans to changes in the actuarial assumptions: Effects on Benefit Obligations in 2024 Effects on Net Periodic Pension Costs in 2025 Millions of dollars U.S. Non-U.S. U.S. Non-U.S.
The discussion summarizing the significant factors affecting the results of operations and financial condition for the year ended December 31, 2021 and for the year ended December 31, 2022 compared to 2021 has been excluded from this Form 10-K and can be found in the update to Part II, “Item 7.
The discussion summarizing the significant factors affecting the results of operations and financial condition for the year ended December 31, 2022 and for the year ended December 31, 2023 compared to 2022 has been excluded from this Form 10-K and can be found in Part II, “Item 7.
Such estimates are consistent with those used in our financial planning and business performance reviews. 53 Table of Conte nts When an income approach is used to estimate fair value of our long-lived assets, the cash flows are discounted using a rate that is based on a variety of factors, including market and economic conditions, operational risk, regulatory risk and political risk.
Such estimates are consistent with those used in our financial planning and business performance reviews. When an income approach is used to estimate fair value of our long-lived assets, the cash flows are discounted using a rate that is based on a variety of factors, including market and economic conditions, operational risk, regulatory risk and political risk.
Share Repurchases In May 2023, our shareholders approved a proposal to authorize us to repurchase up to 34.0 million ordinary shares, through November 19, 2024, which superseded any prior repurchase authorizations. Our share repurchase authorization does not have a stated dollar amount, and purchases may be made through open market purchases, private market transactions or other structured transactions.
Share Repurchases In May 2024, our shareholders approved a proposal to authorize us to repurchase up to 34.0 million ordinary shares, through November 24, 2025, which superseded any prior repurchase authorizations. Our share repurchase authorization does not have a stated dollar amount, and purchases may be made through open market purchases, private market transactions or other structured transactions.
Our assumed discount rate is based on yield information for high-quality corporate bonds with durations comparable to the expected cash settlement of our obligations. For the purpose of measuring the benefit obligations at December 31, 2023, we used a weighted average discount rate of 5.80% for the U.S. plans, which reflects the different terms of the related benefit obligations.
Our assumed discount rate is based on yield information for high-quality corporate bonds with durations comparable to the expected cash settlement of our obligations. For the purpose of measuring the benefit obligations at December 31, 2024, we used a weighted average discount rate of 5.35% for the U.S. plans, which reflects the different terms of the related benefit obligations.
Inherent in such policies are certain key assumptions and estimates made by management and updated periodically based on its latest assessment of the current and projected business and general economic environment. 52 Table of Conte nts Management believes the following accounting policies and estimates, and the judgments and uncertainties affecting them, are critical in understanding our reported operating results and financial condition.
Inherent in such policies are certain key assumptions and estimates made by management and updated periodically based on its latest assessment of the current and projected business and general economic environment. Management believes the following accounting policies and estimates, and the judgments and uncertainties affecting them, are critical in understanding our reported operating results and financial condition.
These purchase arrangements include provisions which state minimum purchase quantities; however, in the event we do not take the contractual minimum volumes, we are obligated to compensate the vendor only for any resulting economic losses they suffer. No material fees were paid to vendors for such losses in 2023.
These purchase arrangements include provisions which state minimum purchase quantities or fixed-fees; however, in the event we do not take the contractual minimum volumes, we are obligated to compensate the vendor only for any resulting economic losses they suffer. No material fees were paid to vendors for such losses in 2024.
Repurchased shares could be retired or used for general corporate purposes, including for various employee benefit and compensation plans. The maximum number of shares that may yet be purchased is not necessarily an indication of the number of shares that will ultimately be purchased. In 2023, we purchased 2.3 million shares under our share repurchase authorization for $211 million.
Repurchased shares could be retired or used for general corporate purposes, including for various employee benefit and compensation plans. The maximum number of shares that may yet be purchased is not necessarily an indication of the number of shares that will ultimately be purchased. In 2024, we purchased 2.2 million shares under our share repurchase authorization for $198 million.
The weighted average expected long-term rate of return on assets in our non-U.S. plans of 3.57% is based on expectations and asset allocations that vary by region. The asset allocations are summarized in Note 15 to the Consolidated Financial Statements.
The weighted average expected long-term rate of return on assets in our non-U.S. plans of 4.14% is based on expectations and asset allocations that vary by region. The asset allocations are summarized in Note 14 to the Consolidated Financial Statements.
For additional information related to our share repurchase authorizations, see Note 19 to the Consolidated Financial Statements. Capital Budget In 2024, we are planning to invest approximately $2.1 billion in capital expenditures. Approximately 60% of the 2024 budget is planned for sustaining maintenance, with the remaining budget supporting profit-generating growth projects.
For additional information related to our share repurchase authorizations, see Note 18 to the Consolidated Financial Statements. Capital Budget In 2025, we are planning to invest approximately $1.9 billion in capital expenditures. Approximately $1.2 billion of the 2025 budget is planned for sustaining maintenance, with the remaining budget supporting profit-generating growth projects.
As of February 20, 2024, we had approximately 33.1 million shares remaining under the current authorization. The timing and amounts of additional shares repurchased, if any, will be determined based on our evaluation of market conditions and other factors, including any additional authorizations approved by our shareholders.
As of February 25, 2025, we had approximately 31.1 million shares remaining under the current authorization. The timing and amounts of additional shares repurchased, if any, will be determined based on our evaluation of market conditions and other factors, including any additional authorizations approved by our shareholders.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES Management applies those accounting policies that it believes best reflect the underlying business and economic events, consistent with accounting principles generally accepted in the U.S., see Note 2 to the Consolidated Financial Statements.
See Note 4 to the Consolidated Financial Statements for additional related party disclosures. CRITICAL ACCOUNTING POLICIES AND ESTIMATES Management applies those accounting policies that it believes best reflect the underlying business and economic events, consistent with accounting principles generally accepted in the U.S., see Note 2 to the Consolidated Financial Statements.
During the fourth quarter of 2022, management performed a qualitative impairment assessment of our reporting units, which indicated that it was more likely than not that the fair value of our reporting units was greater than their carrying value including goodwill. Accordingly, a quantitative goodwill impairment test was not required.
In the fourth quarter of 2024, we performed a qualitative impairment assessment of our reporting units, which indicated that it was more likely than not that the fair value of our reporting units was greater than their carrying value including goodwill. Accordingly, a quantitative goodwill impairment test was not required.
The weighted average discount rate used to measure obligations for non-U.S. plans at December 31, 2023, was 4.00%, reflecting market interest rates. The discount rates in effect at December 31, 2023 will be used to measure net periodic benefit cost during 2024.
The weighted average discount rate used to measure obligations for non-U.S. plans at December 31, 2024, was 3.66%, reflecting market interest rates. The discount rates in effect at December 31, 2024 will be used to measure net periodic benefit cost during 2025.
Cash and Liquid Investments As of December 31, 2023, we had Cash and cash equivalents totaling $3,390 million, which includes $1,816 million in jurisdictions outside of the U.S., primarily held within the European Union and the United Kingdom. There are currently no legal or economic restrictions that would materially impede our transfers of cash.
Cash and Liquid Investments As of December 31, 2024, we had Cash and cash equivalents totaling $3,375 million, which includes $1,172 million in jurisdictions outside of the U.S., primarily held within the European Union. There are currently no legal or economic restrictions that would materially impede our transfers of cash.
Comprehensive Income— Comprehensive income decreased by $2,303 million in 2023 compared to 2022, primarily due to a decrease in net income. The activities from the remaining components of Comprehensive income are discussed below.
Comprehensive Income— Comprehensive income decreased by $706 million in 2024 compared to 2023, primarily due to a decrease in net income. The activities from the remaining components of Comprehensive income are discussed below.
For more information regarding our debt arrangements, lease obligations, pension and other post-retirement benefits and income taxes, see Notes 12, 13, 15 and 17 to the Consolidated Financial Statements, respectively.
For more information regarding our debt arrangements, lease obligations, pension and other post-retirement benefits and income taxes, see Notes 11, 12, 14 and 16 to the Consolidated Financial Statements, respectively.
We had total unused availability under our credit facilities of $4,150 million at December 31, 2023, which included the following: • $3,250 million under our $3,250 million Senior Revolving Credit Facility, which backs our $2,500 million commercial paper program.
We had total unused availability under our credit facilities of $4,650 million at December 31, 2024, which included the following: • $3,750 million under our $3,750 million Senior Revolving Credit Facility. This facility backs our $2,500 million commercial paper program.
ACCOUNTING AND REPORTING CHANGES For a discussion of the potential impact of new accounting pronouncements on our Consolidated Financial Statements, see Note 2 to the Consolidated Financial Statements. 57 Table of Conte nts
ACCOUNTING AND REPORTING CHANGES For a discussion of the potential impact of new accounting pronouncements on our Consolidated Financial Statements, see Note 2 to the Consolidated Financial Statements. 52 Table of Conten ts
Goodwill —As of December 31, 2023, we had goodwill of $1,647 million, primarily relating to the acquisition of A.
Goodwill —As of December 31, 2024, we had goodwill of $1,561 million, primarily relating to the acquisition of A.
Credit Arrangements At December 31, 2023, we had total debt, including current maturities, of $11,232 million, and $171 million of outstanding letters of credit, bank guarantees and surety bonds issued under uncommitted credit facilities.
Credit Arrangements At December 31, 2024, we had total debt, including current maturities, of $11,149 million. Additionally, we had $174 million of outstanding letters of credit, bank guarantees and surety bonds issued under uncommitted credit facilities.
See Notes 8 and 21 to the Consolidated Financial Statements. 54 Table of Conte nts An estimate of the sensitivity to net income resulting from impairment calculations is not practicable, given the numerous assumptions, including pricing, volumes and discount rates, which could materially affect our estimates.
See Notes 7 and 20 to the Consolidated Financial Statements. 49 Table of Conten ts An estimate of the sensitivity to net income resulting from impairment calculations is not practicable, given the numerous assumptions, including pricing, volumes and discount rates, which could materially affect our estimates.
Ethylene Raw Materials —In Europe, naphtha is the primary raw material for our ethylene production and represents approximately 65% to 70% of the raw materials used in 2023 and 2022. The following table sets forth selected financial information for the O&P-EAI segment including Loss from equity investments, which is a component of EBITDA.
Ethylene Raw Materials —In Europe, naphtha is the primary raw material for our ethylene production and represented approximately 60% and 65% of the raw materials used in 2024 and 2023, respectively. 40 Table of Conten ts The following table sets forth selected financial information for the O&P-EAI segment including Loss from equity investments, which is a component of EBITDA.
Since our inventory consists of manufactured products derived from crude oil, natural gas, natural gas liquids and correlated materials, as well as the associated feedstocks and intermediate chemicals, our inventory market values are generally influenced by changes in the benchmark of crude oil and heavy liquid values and prices for manufactured finished goods.
Crude oil and natural gas prices are subject to many factors, including changes in economic conditions. 47 Table of Conten ts Since our inventory consists of manufactured products derived from crude oil, natural gas, natural gas liquids and correlated materials, as well as the associated feedstocks and intermediate chemicals, our inventory market values are generally influenced by changes in the benchmark of crude oil and heavy liquid values and prices for manufactured finished goods.
See Notes 14, 15 and 19 to the Consolidated Financial Statements for further discussions. 41 Table of Conte nts Segment Analysis We use earnings from continuing operations before interest, income taxes, and depreciation and amortization (“EBITDA”) as our measure of profitability for segment reporting purposes.
See Notes 13, 14 and 18 to the Consolidated Financial Statements for further discussions. 37 Table of Conten ts Segment Analysis We use earnings from continuing operations before interest, income taxes, and depreciation and amortization (“EBITDA”) as our measure of profitability for segment reporting purposes.
Upon settlement of these foreign currency contracts, we paid €750 million ($820 million at the expiry spot rate) to our counterparties and received $903 million from our counterparties. In 2022, foreign currency contracts with an aggregate notional value of €500 million expired.
In 2024, foreign currency contracts with an aggregate notional value of €850 million expired. Upon settlement of these foreign currency contracts, we paid €850 million ($921 million at the expiry spot rate) to our counterparties and received $967 million from our counterparties. In 2023, foreign currency contracts with an aggregate notional value of €750 million expired.
The following table presents the reconciliation of Net Income to EBITDA for each of the periods presented: Year Ended December 31, Millions of U.S. dollars 2023 2022 Net income $ 2,121 $ 3,889 Loss from discontinued operations, net of tax 5 5 Income from continuing operations 2,126 3,894 Provision for income taxes 501 882 Depreciation and amortization 1,534 1,267 Interest expense, net 348 258 EBITDA $ 4,509 $ 6,301 42 Table of Conte nts Our continuing operations are managed through six reportable segments: O&P-Americas, O&P-EAI, I&D, APS, Refining and Technology.
The following table presents the reconciliation of Net Income to EBITDA for each of the periods presented: Year Ended December 31, Millions of dollars 2024 2023 Net income $ 1,367 $ 2,121 (Income) loss from discontinued operations, net of tax (4) 5 Income from continuing operations 1,363 2,126 Provision for income taxes 240 501 Depreciation and amortization 1,522 1,534 Interest expense, net 331 348 EBITDA $ 3,456 $ 4,509 Our continuing operations are managed through six reportable segments: O&P-Americas, O&P-EAI, I&D, APS, Refining and Technology.
In the fourth quarter of 2023, we performed a quantitative impairment assessment for our reporting units within our Advanced Polymer Solutions segment and a qualitative impairment assessment of our other reporting units, which indicated that the fair value of our reporting units was greater than their carrying value including goodwill.
In the fourth quarter of 2023, management performed a quantitative impairment assessment for our reporting units within our APS segment and a qualitative impairment assessment of our other reporting units, which indicated that the fair values of our reporting units were greater than their carrying values, including goodwill.
Investment returns that are recognized currently in net income represent the expected long-term rate of return on plan assets applied to a market-related value of plan assets, which is defined as the market value of assets.
The net periodic benefit cost of pension benefits included in expense is affected by the expected long-term rate of return on plan assets assumption. Investment returns that are recognized currently in net income represent the expected long-term rate of return on plan assets applied to a market-related value of plan assets, which is defined as the market value of assets.
This discount rate is also compared to recent observable market transactions, if possible. Equity Method Investments Impairment —Investments in nonconsolidated entities accounted for under the equity method are assessed for impairment when there are indicators of a loss in value, such as a lack of sustained earnings capacity or a current fair value less than the investment’s carrying amount.
Equity Method Investments Impairment —Investments in nonconsolidated entities accounted for under the equity method are assessed for impairment when there are indicators of a loss in value, such as a lack of sustained earnings capacity or a current fair value less than the investment’s carrying amount.
Additionally, in 2023 and 2022, we made payments of $211 million and $420 million to repurchase outstanding ordinary shares, respectively. For additional information related to our share repurchases and dividend payments, see Note 19 to the Consolidated Financial Statements. 49 Table of Conte nts In 2023, we issued $500 million of 5.625% guaranteed notes due 2033.
Additionally, in 2024 and 2023, we made payments of $195 million and $211 million to repurchase outstanding ordinary shares, respectively. For additional information related to our share repurchases and dividend payments, see Note 18 to the Consolidated Financial Statements. In 2024, we issued $750 million of 5.5% guaranteed notes due 2034.
Impairments —During 2023, we recognized non-cash impairment charges of $518 million, primarily consisting of a goodwill impairment charge of $252 million in our APS segment and an impairment charge of $192 million related to our European PO joint venture recognized in our I&D segment.
During 2023, we recognized non-cash impairment charges of $518 million, primarily consisting of a goodwill impairment charge of $252 million in our APS segment and an impairment charge of $192 million related to our European PO joint venture recognized in our I&D segment. See Notes 7, 8 and 20 to the Consolidated Financial Statements for additional information regarding impairment charges.
At the end of 2023, we estimated VEP benefits to have a year-end annual run rate of approximately $300 million of Net income which, after adding back income taxes and depreciation and amortization of $75 million and $25 million, respectively, results in approximately $400 million of recurring annual EBITDA, which exceeded our original expectations.
At the end of 2024, we estimated VEP benefits to have a year-end annual run rate of approximately $610 million of Net income which, after adding back income taxes and depreciation and amortization of $155 million and $35 million, respectively, results in approximately $800 million of recurring annual EBITDA.
Foreign currency translations increased Comprehensive income by $196 million in 2023 compared to 2022, primarily due to the weakening of the U.S. dollar relative to the euro and the British pound sterling in 2023, offset by the effective portion of our net investment hedges.
Foreign currency translations decreased Comprehensive income by $242 million in 2024 compared to 2023, primarily due to the strengthening of the U.S. dollar relative to the euro in 2024, offset by the effective portion of our net investment hedges.
Projected benefit obligations at December 31, 2023 $ 1,155 $ 1,363 $ — $ — Projected net periodic pension costs in 2024 — — 69 54 Discount rate increases by 100 basis points (95) (172) (7) (6) Discount rate decreases by 100 basis points 112 200 8 7 The sensitivity of our post-retirement benefit plans obligations and net periodic benefit costs to changes in actuarial assumptions are reflected in the following table: Effects on Benefit Obligations in 2023 Effects on Net Periodic Benefit Costs in 2024 Millions of dollars U.S.
Projected benefit obligations at December 31, 2024 $ 1,232 $ 1,389 $ — $ — Projected net periodic pension costs in 2025 — — 59 54 Discount rate increases by 100 basis points (101) (176) (7) (5) Discount rate decreases by 100 basis points 120 205 9 7 The sensitivity of our post-retirement benefit plans obligations and net periodic benefit costs to changes in actuarial assumptions are reflected in the following table: Effects on Benefit Obligations in 2024 Effects on Net Periodic Benefit Costs in 2025 Millions of dollars U.S.
Deferred tax assets and liabilities are determined based on temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, and are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse.
Deferred tax assets and liabilities are determined based on temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. 51 Table of Conten ts We recognize future tax benefits to the extent that the realization of these benefits is more likely than not.
Intersegment eliminations and items that are not directly related or allocated to business operations, such as foreign exchange gains (losses) and components of pension and other post-retirement benefit costs other than service cost, are included in “Other.” For additional information related to our operating segments, as well as a reconciliation of EBITDA to its nearest generally accepted accounting principles (“GAAP”) measure, Income from continuing operations before income taxes, see Note 21 to our Consolidated Financial Statements.
Intersegment eliminations and items that are not directly related or allocated to business operations, such as foreign exchange gains or losses and components of pension and other post-retirement benefits other than service costs, are included in “Other.” See the table below for a reconciliation of EBITDA to its nearest generally accepted accounting principles (“GAAP”) measure.
We recognize future tax benefits to the extent that the realization of these benefits is more likely than not. Our current provision for income taxes is impacted by the recognition and release of valuation allowances related to net deferred tax assets in certain jurisdictions.
Our current provision for income taxes is impacted by the recognition and release of valuation allowances related to net deferred tax assets in certain jurisdictions.
Given its performance in 2023, we anticipate that our VEP will achieve a 2024 year-end annual run rate of approximately $445 million of Net income, which, after adding back income taxes and depreciation and amortization of approximately $110 million and $45 million, respectively, results in approximately $600 million of recurring annual EBITDA.
We anticipate that our VEP will achieve a 2025 year-end annual run rate of approximately $760 million of Net income, which, after adding back income taxes and depreciation and amortization of approximately $190 million and $50 million, respectively, results in approximately $1,000 million of recurring annual EBITDA.
During 2023, we recognized a non-cash goodwill impairment charge of $252 million after the effect of moving our Catalloy and polybutene-1 businesses from our APS segment and reintegrating them into our O&P-Americas and O&P-EAI segments. This impairment charge resulted in a 219% decrease in EBITDA. See Note 8 to the Consolidated Financial Statements for additional information.
EBITDA —EBITDA increased in 2024 by $216 million, or 133%, compared to 2023. During 2023, we recognized a non-cash goodwill impairment charge of $252 million after the effect of moving our Catalloy and polybutene-1 businesses from our APS segment and reintegrating them into our O&P-Americas and O&P-EAI segments.
Year Ended December 31, Millions of dollars 2023 2022 Sales and other operating revenues $ 41,107 $ 50,451 Cost of sales 35,849 43,847 Impairments 518 69 Selling, general and administrative expenses 1,557 1,310 Research and development expenses 130 124 Operating income 3,053 5,101 Interest expense (477) (287) Interest income 129 29 Other expense, net (58) (72) (Loss) income from equity investments (20) 5 Income from continuing operations before income taxes 2,627 4,776 Provision for income taxes 501 882 Income from continuing operations 2,126 3,894 Loss from discontinued operations, net of tax (5) (5) Net income 2,121 3,889 Other comprehensive income (loss), net of tax – Financial derivatives (80) 208 Defined benefit pension and other postretirement benefit plans (97) 346 Foreign currency translations 73 (123) Total other comprehensive (loss) income, net of tax (104) 431 Comprehensive income $ 2,017 $ 4,320 RESULTS OF OPERATIONS Revenues —Revenues decreased by $9,344 million, or 19%, in 2023 compared to 2022.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 40,302 $ 41,107 Cost of sales 35,738 35,849 Impairments 949 518 Selling, general and administrative expenses 1,663 1,557 Research and development expenses 135 130 Operating income 1,817 3,053 Interest expense (481) (477) Interest income 150 129 Gain on sale of business 284 — Other income (expense), net 50 (58) Loss from equity investments (217) (20) Income from continuing operations before income taxes 1,603 2,627 Provision for income taxes 240 501 Income from continuing operations 1,363 2,126 Income (loss) from discontinued operations, net of tax 4 (5) Net income 1,367 2,121 Other comprehensive income (loss), net of tax – Financial derivatives 115 (80) Defined benefit pension and other postretirement benefit plans (2) (97) Foreign currency translations (169) 73 Total other comprehensive income (loss), net of tax (56) (104) Comprehensive income $ 1,311 $ 2,017 RESULTS OF OPERATIONS Revenues —Revenues decreased by $805 million, or 2%, in 2024 compared to 2023.
Approximately half of our profit-generating growth project budget, or $400 million, is for projects that support our sustainability goals. Cash Requirements from Contractual and Other Obligations As part of our ongoing operations, we enter into contractual arrangements that may require us to make future cash payments under certain circumstances.
Cash Requirements from Contractual and Other Obligations As part of our ongoing operations, we enter into contractual arrangements that may require us to make future cash payments under certain circumstances.
Year Ended December 31, Millions of dollars 2023 2022 Sales and other operating revenues $ 3,698 $ 4,202 Loss from equity investments (1) — EBITDA (162) 115 Revenues —Revenues decreased in 2023 by $504 million, or 12%, compared to 2022. Average sales price declines resulted in an 11% decrease in revenue as a result of lower demand.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 3,634 $ 3,698 Loss from equity investments — (1) EBITDA 54 (162) Revenues —Revenues decreased in 2024 by $64 million, or 2%, compared to 2023 as a result of lower average sales prices.
At December 31, 2023 we had no borrowings or letters of credit outstanding under this facility. 50 Table of Conte nts At any time and from time to time, we may repay or redeem our outstanding debt, including purchases of our outstanding bonds in the open market, through privately negotiated transactions or a combination thereof, in each case using cash and cash equivalents, cash from our short-term investments, cash from operating activities, proceeds from the issuance of debt or proceeds from asset divestitures.
See Note 11 to the Consolidated Financial Statements for additional details. 45 Table of Conten ts At any time and from time to time, we may repay or redeem our outstanding debt, including purchases of our outstanding bonds in the open market, through privately negotiated transactions or a combination thereof, in each case using cash and cash equivalents, cash from our short-term investments, cash from operating activities, proceeds from the issuance of debt or proceeds from asset divestitures.
Upon settlement of these foreign currency contracts, we paid €500 million ($501 million at the expiry spot rate) to our counterparties and received $614 million from our counterparties. Financing Activities —We made dividend payments totaling $1,610 million and $3,246 million, in 2023 and 2022, respectively. The 2022 dividend payments included a special dividend of $5.20 per share totaling $1,704 million.
Upon settlement of these foreign currency contracts, we paid €750 million ($820 million at the expiry spot rate) to our counterparties and received $903 million from our counterparties. Financing Activities —We made dividend payments totaling $1,720 million and $1,610 million, in 2024 and 2023, respectively.
Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2022 as reported in Exhibit 99.1 to the Current Report on form 8-K of the Company filed with the Securities and Exchange Commission on May 12, 2023 and is incorporated herein by reference.
Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2023 which was filed with the Securities and Exchange Commission on February 22, 2024 of which Item 7 is incorporated herein by reference.
Availability under this facility is subject to a borrowing base of eligible receivables, which is reduced by outstanding borrowings and letters of credit, if any.
Availability under this facility is subject to a borrowing base of eligible receivables, which is reduced by outstanding borrowings and letters of credit, if any. At December 31, 2024, we had no borrowings or letters of credit outstanding under this facility. In 2024, we amended some terms of our credit agreements.
Although prices of crude-based liquids and natural gas liquids are generally related to crude oil and natural gas prices, during specific periods the relationships among these materials and benchmarks may vary significantly.
Although prices of crude-based liquids and natural gas liquids are generally related to crude oil and natural gas prices, during specific periods the relationships among these materials and benchmarks may vary significantly. Ethane made up approximately 75% and 70% of the raw materials used in our North American crackers in 2024 and 2023, respectively.
In 2022, the main components of working capital provided $450 million of cash driven by a decrease in Accounts receivable, partially offset by a decrease in Accounts payable. The decrease in Accounts receivable was primarily due to lower revenues across most businesses primarily driven by lower average sales prices.
In 2024, the main components of working capital provided $30 million of cash driven by a decrease in Accounts receivable and Inventories, partially offset by a decrease in Accounts payable. The decrease in Accounts receivable was due to lower average sales prices coupled with timing of sales and customer payments.
The weighted average expected long-term rate of return on assets in our U.S. plans of 7.25% is based on the average level of earnings that our independent pension investment advisor advised could be expected to be earned over time.
The expected rate of return on plan assets is a longer-term rate and is expected to change less frequently than the current assumed discount rate, reflecting long-term market expectations, rather than current fluctuations in market conditions. 50 Table of Conten ts The weighted average expected long-term rate of return on assets in our U.S. plans of 7.25% is based on the average level of earnings that our independent pension investment advisor advised could be expected to be earned over time.
These revenues are offset in part by the costs incurred in the production of catalysts, licensing and services activities and research and development (“R&D”) activities. In 2023 and 2022, our Technology segment incurred approximately 50% to 55% of all R&D costs.
Technology Segment Overview —Our Technology segment recognizes revenues related to the sale of polyolefin catalysts and the licensing of chemical and polyolefin process technologies. These revenues are offset in part by the costs incurred in the production of catalysts, licensing and services activities and research and development (“R&D”) activities.
The benefit obligation and the net periodic benefit cost of other post-retirement medical benefits are also measured based on assumed rates of future increase in the per capita cost of covered health care benefits.
The benefit obligation and the net periodic benefit cost of other post-retirement medical benefits are also measured based on assumed rates of future increase in the per capita cost of covered health care benefits. As of December 31, 2024, the assumed rate of increase for our U.S. plans was 6.5%, decreasing to 4.5% in 2033 and thereafter.
In 2023, the main components of working capital provided $269 million of cash driven by a decrease in Accounts receivable and an increase in Accounts payable. The decrease in Accounts receivable was primarily due to lower revenues in our O&P-Americas, O&P-EAI and APS segments, primarily driven by lower average sales prices.
The decrease in Accounts receivable was primarily due to lower revenues in our O&P-Americas, O&P-EAI and APS segments, primarily driven by lower average sales prices. The increase in Accounts payable was primarily driven by higher feedstock and energy costs in our O&P-Americas segment.
Year Ended December 31, Millions of dollars 2023 2022 Sales and other operating revenues $ 9,714 $ 11,893 EBITDA 379 921 Thousands of barrels per day Heavy crude oil processing rates 237 238 Market margins, dollars per barrel Brent - 2-1-1 $ 25.71 $ 33.62 Brent - Maya differential 13.26 11.71 Total Maya 2-1-1 $ 38.97 $ 45.33 47 Table of Conte nts Revenues —Revenues decreased by $2,179 million, or 18%, in 2023 compared to 2022.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 8,559 $ 9,714 EBITDA (60) 379 Thousands of barrels per day Heavy crude oil processing rates 237 237 Market margins, dollars per barrel Brent - 2-1-1 $ 16.16 $ 25.71 Brent - Maya differential 11.49 13.26 Total Maya 2-1-1 $ 27.65 $ 38.97 Revenues —Revenues decreased by $1,155 million, or 12%, in 2024 compared to 2023 driven by lower product prices reflecting lower margins on refined products. 42 Table of Conten ts EBITDA —EBITDA decreased by $439 million or 116%, in 2024 compared to 2023.
Higher licensing revenues resulting from more contracts reaching significant milestones drove a 1% increase in revenue. EBITDA —EBITDA in 2023 increased by $9 million, or 2%, compared to 2022. Higher catalyst margins resulted in a 5% increase in EBITDA.
Higher catalyst prices drove a 1% increase in revenues. Lower catalyst volumes resulting from lower demand drove a 3% decrease in revenues. EBITDA —EBITDA in 2024 increased by $4 million, or 1%, compared to 2023. Licensing results led to a 6% increase in EBITDA resulting from more contracts reaching significant milestones.
Defined benefit pension and other postretirement benefit plans led to a decrease in Comprehensive income of $443 million in 2023 compared to 2022, primarily due to actuarial losses resulting from lower-than-expected asset returns combined with the absence of pre-tax pension settlements in 2023.
Defined benefit pension and other postretirement benefit plans led to an increase in Comprehensive income of $95 million in 2024 compared to 2023, primarily due to actuarial gains resulting from higher-than-expected asset returns offset by a decrease in discount rates.
Year Ended December 31, Millions of dollars 2023 2022 Sales and other operating revenues $ 11,086 $ 12,950 Loss from equity investments (13) (25) EBITDA 1,679 1,872 Revenues —Revenues decreased by $1,864 million, or 14%, in 2023 compared to 2022. Lower average sales prices resulted in a 20% decrease in revenue as a result of lower demand.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 10,424 $ 11,086 Loss from equity investments (13) (13) EBITDA 1,664 1,679 Revenues —Revenues decreased by $662 million, or 6%, in 2024 compared to 2023 driven by lower average sales prices for oxyfuels and related products as a result of lower gasoline crack spreads and blend premiums.
These arrangements largely relate to product off-take agreements with a joint venture located in Poland . No material shortfall was paid for quantities not taken under these contracts in 2023.
We also have purchase obligations under take-or-pay agreements which require us to either buy and take delivery of a minimum quantity of goods or to pay for any shortfall. These arrangements largely relate to product off-take agreements with a joint venture located in Poland . No material shortfall was paid for quantities not taken under these contracts in 2024.
Favorable foreign exchange impacts resulted in an EBITDA increase of 3%. 48 Table of Conte nts FINANCIAL CONDITION Operating, investing and financing activities of continuing operations, which are discussed below, are presented in the following table: Year Ended December 31, Millions of dollars 2023 2022 Cash provided by (used in): Operating activities $ 4,942 $ 6,119 Investing activities (1,777) (1,977) Financing activities (1,950) (3,407) Operating Activities —Cash provided by operating activities of $4,942 million in 2023 primarily reflected earnings adjusted for non-cash items and cash used by the main components of working capital–Accounts receivable, Inventories and Accounts payable.
Lower catalyst volumes driven by lower demand resulted in a 4% decrease in EBITDA. 43 Table of Conten ts FINANCIAL CONDITION The following table summarizes operating, investing and financing cash flow activities: Year Ended December 31, Millions of dollars 2024 2023 Cash provided by (used in): Operating activities $ 3,819 $ 4,942 Investing activities (1,853) (1,777) Financing activities (1,895) (1,950) Operating Activities —Cash provided by operating activities of $3,819 million in 2024 primarily reflected earnings adjusted for non-cash items and cash used by the main components of working capital–Accounts receivable, Inventories and Accounts payable.
Ethane made up approximately 70% of the raw materials used in our North American crackers in 2023 and 2022. 44 Table of Conte nts The following table sets forth selected financial information for the O&P-Americas segment including Income from equity investments, which is a component of EBITDA.
The following table sets forth selected financial information for the O&P-Americas segment including Income from equity investments, which is a component of EBITDA.
RELATED PARTY TRANSACTIONS We have related party transactions with our joint venture partners. We believe that such transactions are effected on terms substantially no more or less favorable than those that would have been agreed upon by unrelated parties on an arm’s length basis. See Note 5 to the Consolidated Financial Statements for additional related party disclosures.
We estimate incurring one-time costs of $200 million in 2025 related to our Value Enhancement Program. RELATED PARTY TRANSACTIONS We have related party transactions with our joint ventures. We believe that such transactions are affected on terms substantially no more or less favorable than those that would have been agreed upon by unrelated parties on an arm’s length basis.
Year Ended December 31, Millions of dollars 2023 2022 Sales and other operating revenues $ 11,280 $ 14,480 Income from equity investments 49 98 EBITDA 2,303 2,865 Revenues —Revenues decreased by $3,200 million, or 22%, in 2023 compared to 2022. Lower average sales prices resulted in a 23% decrease in revenue primarily driven by increased market supply and lower demand.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 11,533 $ 11,280 Income from equity investments 13 49 EBITDA 2,445 2,303 Revenues —Revenues increased by $253 million, or 2%, in 2024 compared to 2023. Higher average sales prices across most of our products resulted in a 5% increase in revenue.
The increase in Accounts payable was primarily driven by higher feedstock and energy costs in our O&P-Americas segment. Cash provided by operating activities of $6,119 million in 2022 primarily reflected earnings adjusted for non-cash items and cash provided by the main components of working capital.
Cash provided by operating activities of $4,942 million in 2023 primarily reflected earnings adjusted for non-cash items and cash provided by the main components of working capital. In 2023, the main components of working capital provided $269 million of cash driven by a decrease in Accounts receivable and an increase in Accounts payable.
“Maya” is a heavy sour crude oil grade produced in Mexico that is a relevant benchmark for heavy sour crude oils in the U.S. Gulf Coast market. References to industry benchmarks for refining market margins are to industry prices reported by Platts, a division of S&P Global.
“Brent” is a light sweet crude oil and is one of the main benchmark prices for purchases of oil worldwide. “Maya” is a heavy sour crude oil grade produced in Mexico that is a relevant benchmark for heavy sour crude oils in the U.S. Gulf Coast market.
Segment results were relatively unchanged as improvements in our oxyfuels and related products results were offset by lower margins for propylene oxide and derivatives and intermediate chemicals. The following table sets forth selected financial information for the I&D segment including Loss from equity investments, which is a component of EBITDA.
Intermediates and Derivatives Segment Overview —EBITDA decreased in 2024 compared to 2023, primarily driven by lower oxyfuels and related products margins as a result of lower crude oil and gasoline pricing combined with lower blend premiums. The following table sets forth selected financial information for the I&D segment including Loss from equity investments, which is a component of EBITDA.
Year Ended December 31, Millions of dollars 2023 2022 Sales and other operating revenues $ 10,479 $ 13,455 Loss from equity investments (55) (68) EBITDA (9) 178 Revenues —Revenues decreased by $2,976 million, or 22%, in 2023 compared to 2022.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 10,867 $ 10,479 Loss from equity investments (217) (55) EBITDA (991) (9) Revenues —Revenues increased by $388 million, or 4%, in 2024 compared to 2023. Higher average sales prices and volumes each resulted in a 2% increase in revenue primarily due to higher demand.
During 2023, we recognized a non-cash impairment charge of $192 million related to our equity investment in the European PO joint venture resulting in a 10% decrease in EBITDA. See Note 9 to the Consolidated Financial Statements for additional information. Excluding the impact of the impairment discussed above, segment results remained relatively unchanged.
During 2023, we recognized a non-cash impairment charge of $192 million related to our equity investment in the European PO joint venture.
The following table sets forth selected financial information and heavy crude oil processing rates for the Refining segment and the U.S. refining market margins for the applicable periods. “Brent” is a light sweet crude oil and is one of the main benchmark prices for purchases of oil worldwide.
Refining Segment Overview —EBITDA decreased in 2024 relative to 2023 primarily due to lower margins. The following table sets forth selected financial information and heavy crude oil processing rates for the Refining segment and the U.S. refining market margins for the applicable periods.
When valued using a contract price as of December 31, 2023, these commitments represent approximately 5% of our annual Cost of sales with a weighted average remaining term of 14 years. CURRENT BUSINESS OUTLOOK In the first quarter of 2024, seasonally slow demand and economic uncertainty provide headwinds for most businesses.
When valued using a contract price as of December 31, 2024, these commitments represent approximately 5% of our annual Cost of sales with a weighted average remaining term of 14 years. 46 Table of Conten ts CURRENT BUSINESS OUTLOOK In 2025 we remain watchful and prepared for the macroeconomic catalysts that will eventually drive restocking of supply chains, improve demand for durable goods and support a more broad-based economic recovery.
We incurred one-time costs of approximately $200 million in 2023 to achieve this milestone.
We incurred one-time costs of approximately $200 million per year in 2023 and 2024 related to our Value Enhancement Program.
In 2023, Operating income decreased for our Refining, O&P-Americas, I&D, APS and O&P-EAI segments by $668 million, $541 million, $342 million, $277 million and $235 million, respectively. Operating income for our Technology segment increased by $3 million in 2023 compared to 2022. Results for each of our business segments are discussed further in the Segment Analysis section below.
In 2024, Operating income decreased for our O&P-EAI, Refining, and I&D segments by $848 million, $434 million and $311 million, respectively. Operating income for our APS, O&P-Americas and Technology segments increased by $213 million, $140 million and $4 million, respectively, in 2024 compared to 2023.
Assuming that contractual minimum volumes are purchased at contract prices as of December 31, 2023, these commitments represent approximately 20% of our annual Cost of sales with a weighted average remaining term of 7 years. 51 Table of Conte nts We also have purchase obligations under take-or-pay agreements which require us to either buy and take delivery of a minimum quantity of goods or to pay for any shortfall.
Assuming that contractual minimum volumes are purchased at contract prices as of December 31, 2024, these commitments represent approximately 15% of our annual Cost of sales with a weighted average remaining term of 8 years.
Unless otherwise indicated, the “Company,” “we,” “us,” “our” or similar words are used to refer to LyondellBasell Industries N.V. together with its consolidated subsidiaries (“LyondellBasell N.V.”). Effective January 1, 2023, our Catalloy and polybutene-1 businesses were moved from the Advanced Polymer Solutions (“APS”) segment and reintegrated into the Olefins and Polyolefins-Americas (“O&P-Americas”) and Olefins and Polyolefins-Europe, Asia, International (“O&P-EAI”) segments.
Unless otherwise indicated, the “Company,” “we,” “us,” “our” or similar words are used to refer to LyondellBasell Industries N.V. together with its consolidated subsidiaries (“LyondellBasell N.V.”).
Favorable foreign exchange impacts resulted in a 1% increase in revenue. Cost of Sales —Cost of sales decreased by $7,998 million, or 18%, in 2023 compared to 2022. This decrease primarily related to lower feedstock and energy costs. Fluctuations in our cost of sales are generally driven by changes in feedstock and energy costs.
Lower average sales prices driven by lower demand resulted in a 2% decrease in revenues. Cost of Sales —Cost of sales remained relatively unchanged, in 2024 compared to 2023. Fluctuations in our cost of sales are generally driven by changes in feedstock and energy costs.